New high-throughput biological sensors track cellular lipid molecules

Inside every cell are lipid molecules that make up cellular membranes, helping organelles communicate and respond to stress. Researchers have struggled to observe lipids in action because current detection tools lack sufficient sensitivity and selectivity, hindering advances in the understanding of lipids.

Now, a team led by researchers at the University of Osaka has developed a method to "evolve" custom biological sensors, making them capable of tracking these molecules in living cells. In a study published this month in Nature Cell Biology, the multidisciplinary team introduced the Cell surface Liposome Binding (CLiB) assay, a high-throughput method that uses yeast cells, liposomes – microscopic capsules made of lipids – and fluorescence readouts to test how thousands of protein variants bind to lipids.

Using the CLiB assay, the team screened a library of protein variants and refined an existing sensor through an evolution-like process, creating a new probe called PX-SnxA^GV. This probe can detect the rare signaling lipid PI(3,5)P₂, which has been notoriously difficult to track because it typically exists in tiny amounts.

In living cells, this probe revealed a surprising pattern: under stress conditions, such as sudden increases in salt, PI(3,5)P₂ accumulates in small, distinct regions of the membrane. Similarly, in mammalian cells undergoing microautophagy – a "self-eating" clean-up process where lysosomes, the cell's recycling centers, directly engulf and break down damaged components – PI(3,5)P₂ is enriched at sites where the membrane begins to fold inward to engulf its cargo.

Beyond these findings, the new CLiB method may have broad applications. Many diseases involve problems with cell membranes, so a better understanding of lipids could open new paths for treatment.

"With these probes, we can now see when and where lipids appear inside cells," explains Nishimura. "These advances will deepen our understanding of membrane lipid environments and how they influence a wide range of diseases, such as cancer, diabetes, and neurodegenerative diseases."

By detecting previously invisible molecules, the CLiB assay provides a new way to study the inner workings of cells, potentially accelerating discoveries across cell biology, medical research, and AI-driven drug development.

Source:

The University of Osaka

Journal reference: